Vorapaxar is an antiplatelet medication used to reduce the risk of thrombotic cardiovascular events in patients with a history of heart attack or peripheral artery disease. It works by antagonizing the protease-activated receptor-1 (PAR-1) on platelets, thereby inhibiting thrombin-induced platelet aggregation. This makes blood less likely to form clots that could lead to strokes or heart attacks. It is typically used in combination with other antiplatelet agents.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Vorapaxar and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Vorapaxar impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Vorapaxar-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
